氨甲环酸用于消化道出血:随机对照试验的系统评价与Meta分析
本研究为系统评价与Meta分析,检索三个生物医学数据库的相关随机对照试验,纳入13项RCT共2271例患者,比较氨甲环酸与安慰剂在消化道出血中的效果。结果显示氨甲环酸显著降低持续出血率(RR=0.60;95%CI 0.43-0.84)、急诊内镜干预率(RR=0.35;95%CI 0.24-0.50)和死亡率(RR=0.60;95%CI 0.45-0.80)。作者结论认为,现有证据证实氨甲环酸对上消化道出血有效,急诊早期给药可能值得推荐;但对下消化道出血的效果尚待进一步明确。
要点
- 13项RCT共2271例消化道出血患者,氨甲环酸较安慰剂显著降低死亡率(RR=0.60;95%CI 0.45-0.80)。
- 氨甲环酸较安慰剂显著降低持续出血率(RR=0.60;95%CI 0.43-0.84)。
- 氨甲环酸较安慰剂显著降低急诊内镜干预率(RR=0.35;95%CI 0.24-0.50)。
- 作者认为,对上消化道出血,急诊早期给药可能值得推荐。
- 作者指出,氨甲环酸对下消化道出血的效果尚待进一步明确。
适用人群与场景
- 消化道出血患者,纳入的13项随机对照试验共2271例。
研究设计与关键结果
- 系统评价与Meta分析,纳入13项随机对照试验,共2271例患者,比较氨甲环酸与安慰剂。
- 氨甲环酸较安慰剂显著降低持续出血率(RR=0.60;95%CI 0.43-0.84)。
- 氨甲环酸较安慰剂显著降低急诊内镜干预率(RR=0.35;95%CI 0.24-0.50)。
- 氨甲环酸较安慰剂显著降低死亡率(RR=0.60;95%CI 0.45-0.80)。
证据类型、等级与局限
- 证据类型:随机对照试验的系统评价与Meta分析。
对床旁实践的改变
- 作者认为,对上消化道出血,急诊早期给予氨甲环酸可能值得推荐。
- 作者指出,氨甲环酸对下消化道出血的效果尚待进一步明确。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Acute gastrointestinal bleeding is a common life-threatening emergent condition. Immediate tranexamic acid is useful for reducing hemorrhage following operation and bleeding trauma, but evidence on the effects of tranexamic acid in patients with gastrointestinal bleeding is limited or highly heterogeneous. It is still unclear about using tranexamic acid in the emergent condition of gastrointestinal bleeding. This study, therefore, aimed to determine whether or not tranexamic acid should be used in gastrointestinal bleeding management through systematic review and meta-analysis.
METHODS: We searched three biomedical databases for relevant randomized controlled trials on this topic. Two authors independently selected studies and extracted data for bias assessment and meta-analysis of bleeding, further intervention, mortality, transfusion, and intensive care unit admission. Available data were pooled using a random-effects model, and the results were presented as risk ratios (RRs) with 95% confidence intervals (CIs). Heterogeneity and small study effects were also assessed.
RESULTS: Thirteen randomized controlled trials (n = 2271) were included in the present synthesis. Our meta-analysis revealed that tranexamic acid significantly reduced the rates of continued bleeding (RR = 0.60; 95%CI, 0.43-0.84), urgent endoscopic intervention (RR = 0.35; 95%CI, 0.24-0.50), and mortality (RR = 0.60; 95%CI, 0.45-0.80) compared with the placebo.
CONCLUSION: According to the available evidence, the present synthesis confirms that tranexamic acid is an effective medication for patients with upper gastrointestinal bleeding. Early administration of tranexamic acid may be worth to be recommended for treating upper gastrointestinal bleeding in the emergency department. However, the effects of tranexamic acid on lower gastrointestinal bleeding warrant further clarification.
参考来源
- Lee PL, Yang KS, Tsai HW, et al. Tranexamic acid for gastrointestinal bleeding: A systematic review with meta-analysis of randomized clinical trials. Am J Emerg Med. 2020. PMID: 33041136. doi:10.1016/j.ajem.2020.08.062
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。